Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The term **"blood-borne toxin"** is not recognized as a specific molecular target, receptor, enzyme, or protein. Instead, it is an imprecise and non-canonical phrase that generally refers to any toxic substance present in the bloodstream. In scientific and medical literature, the more accurate terms are **"bloodborne pathogen"** (referring to infectious microorganisms such as viruses and bacteria carried in blood that cause disease) or **specific toxins** (such as bacterial exotoxins like tetanus toxin). Bloodborne pathogens include hepatitis B virus (HBV), hepatitis C virus (HCV), human immunodeficiency virus (HIV), malaria parasites, syphilis-causing bacteria, among others[1][2][3][4][5]. However, none of these are referred to collectively as "blood-borne toxins," nor does this phrase denote a single molecule or therapeutic target. If you seek information on a particular pathogenic agent or toxic molecule found in blood—such as botulinum neurotoxin or diphtheria toxin—please specify the exact name for structured data extraction. **Summary:** The entry “blood-borne toxin” is incorrect for use as a canonical drug discovery/therapeutic target because it does not refer to any single defined molecule but rather an overly broad and ambiguous concept encompassing many unrelated substances[3][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Blood-borne toxin.